Author:
Hamadjida Adjia,Nuara Stephen G.,Kwan Cynthia,Frouni Imane,Bédard Dominique,Gourdon Jim C.,Huot Philippe
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,General Medicine
Reference41 articles.
1. Amrein R, Stabl M, Henauer S, Affolter E, Jonkanski I (1997) Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview. Can J Psychiatr 42(10):1043–1050.
https://doi.org/10.1177/070674379704201005
2. Bandelow B (2020) Current and novel psychopharmacological drugs for anxiety disorders. Adv Exp Med Biol 1191:347–365.
https://doi.org/10.1007/978-981-32-9705-0_19
3. Bonnet U (2002) Moclobemide: evolution, pharmacodynamic, and pharmacokinetic properties. CNS Drug Rev 8(3):283–308.
https://doi.org/10.1111/j.1527-3458.2002.tb00229.x
4. Chiuccariello L, Cooke RG, Miler L, Levitan RD, Baker GB, Kish SJ, Kolla NJ, Rusjan PM, Houle S, Wilson AA, Meyer JH (2015) Monoamine oxidase-a occupancy by moclobemide and phenelzine: implications for the development of monoamine oxidase inhibitors. Int J Neuropsychopharmacol 19(1):pyv078.
https://doi.org/10.1093/ijnp/pyv078
5. Colzi A, D’Agostini F, Cesura AM, Borroni E, Da Prada M (1993) Monoamine oxidase-A inhibitors and dopamine metabolism in rat caudatus: evidence that an increased cytosolic level of dopamine displaces reversible monoamine oxidase-A inhibitors in vivo. J Pharmacol Exp Ther 265(1):103–111
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献